Targeting the CLDN-LILRB axis inhibits the activity of immunosuppressive myeloid cells and suppresses tumor progression. ...
Targeting the CLDN-LILRB axis inhibits the activity of immunosuppressive myeloid cells and suppresses tumor progression. ...
Our website uses cookies to improve your experience. Learn more about: Cookie Policy